UFE Uterine Fibroid Embolization in Queens, NY

Uterine Fibroid Embolization at Medex Diagnostic & Treatment Center in Queens lets you shrink troublesome fibroids without surgery: our board-certified interventional radiologists guide a tiny catheter through the wrist or groin to block the fibroid’s blood supply, easing heavy bleeding and pelvic pressure within weeks, while on-site imaging, labs, and insurance coordination mean you’re back home the same day and back to normal activities in about a week—all with your uterus preserved for future fertility.

What Is Uterine Fibroid Embolization?

Uterine Fibroid Embolization (UFE), sometimes called uterine artery embolization (UAE), is a catheter-based, image-guided therapy performed by an interventional radiologist (IR). Through a 2-3 mm puncture (wrist or groin), the IR advances a micro-catheter into the uterine arteries and releases tiny, biocompatible microspheres. These particles occlude the arterioles that feed fibroids, starving the tumors of oxygen so they shrink and symptoms recede. Because the rest of the uterus has a rich collateral blood supply, normal tissue survives while the fibroids involute.

Uterine fibroids

Uterine fibroids – benign tumors of smooth – muscle origin – are almost a rite of passage for people with a uterus: 20 % to 80 % of women will develop at least one fibroid by age 50 in the United States womenshealth.gov. Large cohort studies show the cumulative incidence climbs even higher—over 70 % in White women and more than 80 % in Black women nihcm.orghealth.ny.gov. In raw numbers, that translates to roughly 26 million U.S. women (ages 15-50) living with fibroids at any given moment swhr.org. Beyond personal suffering, fibroids cost society an estimated $35 billion annually in lost productivity and direct medical expenses evtoday.com.

Clinical data stretching back two decades confirm that 85 %-90 % of patients experience durable relief of heavy bleeding, pelvic pressure, and pain within three months. MRI studies demonstrate an average 50 %-60 % reduction in fibroid volume at one year, with parallel gains in energy and quality of life.

Why UFE Is Needed: Closing the Treatment Gap

Historically, treatment choices were stark: live with symptoms, or undergo hysterectomy or myomectomy—both major surgeries with multi-week recovery. Surveys commissioned by the Society of Interventional Radiology (SIR) reveal that 17 % of U.S. women still believe hysterectomy is the only option and 49 % have never heard of UFE sirweb.org. By offering a uterus-preserving, same-day alternative, UFE fills the “middle ground” for patients whose medications and hormonal IUDs no longer suffice but who wish to avoid—or delay—open surgery.

Who Is an Ideal Candidate?

  • Symptomatic fibroids causing heavy menstrual bleeding, pelvic pain, pressure on the bladder or bowel, anemia, or infertility.
  • Single or multiple fibroids of any location (submucosal, intramural, subserosal) provided malignancy has been ruled out.
  • Patients who desire uterine conservation or cannot undergo surgery due to medical comorbidities.
  • Women planning future pregnancy: Level-1 evidence from 2024 meta-analyses shows no significant difference in live-birth or miscarriage rates between UFE and myomectomy, busting the old fertility myth link.springer.com.

Contra-indications include suspected uterine sarcoma, active pelvic infection, uncorrected bleeding disorders, or severe allergy to iodinated contrast.

Disparities to Know

Black women are diagnosed three times more often than White women, present at younger ages, and endure larger, faster-growing tumors self.com. They also face higher hysterectomy rates, partly because of structural barriers to minimally invasive care. Expanding UFE awareness is therefore an equity imperative.

The Multidisciplinary Care Team

SpecialistRole in UFE Care Pathway
Interventional Radiologist (IR)Performs angiography and embolization; manages peri-procedural care
Obstetrician-GynecologistScreens for fibroids, rules out malignancy, co-manages fertility and pregnancy issues
Anesthesiologist / CRNAProvides moderate (conscious) sedation or monitored anesthesia
Nursing & Radiologic TechnologistsAssist with catheterization, imaging, and post-procedure monitoring
Primary Care / HematologyOptimizes anemia, hypertension, or other comorbidities before UFE
Reproductive Endocrinology (if fertility desired)Counsels on timelines for conception and assists with IVF if needed

Step-by-Step: What Happens During UFE?

  1. Pre-procedure work-up: Pelvic MRI or contrast ultrasound pinpoints fibroid size and location; labs check hemoglobin, renal function, and coagulation.
  2. Access & angiography: A sheath is inserted into the radial or femoral artery. Under live fluoroscopy, the IR maps both uterine arteries and their branches.
  3. Targeted embolization: Calibrated microspheres (300-500 µm) are injected until blood flow to each fibroid stasis. Average fluoroscopy time is ~15 minutes and radiation dose is well below FDA thresholds.
  4. Closure & recovery: The puncture site is sealed; patients rest for 2-3 hours and then go home the same day with NSAIDs and a short steroid taper. Typical return to desk work occurs in 7-11 days houstonfibroids.com.

UFE Efficacy at a Glance

Clinical Endpoint3 Months12 Months5 Years
Symptom-control rate87 %90 %82 %
Mean fibroid volume reduction42 %55 %60 %
Patient satisfaction91 %88 %
Major complication rate2.9 %2.9 %

No procedure-related deaths have been reported in modern series comprising more than 8,000 patients pubmed.ncbi.nlm.nih.gov.


Recovery Timeline

  • Days 1-3: Cramp-like pelvic pain managed with NSAIDs and limited opioids. Low-grade fever (< 38.5 °C) is common.
  • Week 2: Energy improves; vaginal discharge lessens; many return to normal activity.
  • Month 3: Heavy bleeding and “bulk” symptoms typically fall by > 80 %.
  • Year 1-5: Sustained quality-of-life gains, with re-intervention rates of 10 %-20 %, comparable to myomectomy.

How Does UFE Compare to Other Treatments?

TreatmentHospital StayRecoveryUterus Preserved?Typical Cost*Long-Term Risks
UFE0 nights1-2 weeksYes$8,500-$15,000Rare ovarian failure (< 1 %), post-embolization syndrome
Myomectomy (open)2-3 nights4-6 weeksYes$11,000-$22,000Adhesions, recurrent fibroids (30 %)
Laparoscopic Myomectomy0-1 nights3-4 weeksYes$10,000-$18,000Same as above
Abdominal Hysterectomy2-3 nights6-8 weeksNo$9,600-$24,000Surgical menopause, longer downtime

*Without insurance; regional variations apply. goodrx.comsciencedirect.com

Beyond the lower direct cost vs. surgery, UFE’s quick recovery slashes indirect costs: a 2024 cost-utility study found that returning to work after 11 days saved an average of $3,500 in lost wages compared with hysterectomy’s six-week downtime. Commercial insurers and most Medicaid programs now cover UFE as a first-line option for symptomatic fibroids, provided malignancy is excluded.

Fertility and Pregnancy Outcomes

Two randomized-trial meta-analyses published in 2024 found no significant difference in live-birth rates or miscarriage rates between women who underwent UFE and those who had myomectomy link.springer.com. Pregnancy is usually deferred six months post-UFE to allow optimal uterine healing. Cesarean-delivery rates mirror the general obstetric population once age and parity are matched.

Risks & Complications—What to Expect

  • Post-embolization syndrome (fever, malaise, myalgia): 10-15 %, usually self-limited.
  • Transient amenorrhea: Age-related; 3 % in women < 40 years, rising to 40 % in women ≥ 50 years virna.mic.ca.
  • Major complications (e.g., sepsis, emergent hysterectomy): < 3 % overall pubmed.ncbi.nlm.nih.gov.
  • Ovarian reserve: AMH levels often dip transiently but return to baseline within a year in premenopausal women.

When compared head-to-head with surgery, UFE shows significantly lower 30-day morbidity and fewer transfusions, according to multiple health-economic analyses.

Frequently Asked Questions

1. How long until my periods improve after UFE?
Most people see lighter periods by the second cycle; maximal benefit emerges at 3-6 months.

2. Can UFE treat very large fibroids (> 10 cm)?
Yes, size alone is not a barrier. Very large uteri may require staged embolization or hydrogel particles.

3. Will I experience early menopause?
The risk of permanent ovarian failure is < 1 % in women under 45; age is the main predictor, not the procedure itself.

4. Is UFE painful?
Expect moderate cramps for 24-48 hours, controllable with oral NSAIDs and limited opioids.

5. How soon can I try to conceive?
Most specialists advise waiting six months, but individualized counseling is essential.

6. Can the fibroids come back?
Treated fibroids rarely regrow, but new fibroids may appear; about 15 % of patients need retreatment within five years.

7. Does insurance cover UFE?
Yes—nearly all major U.S. plans and Medicare recognize UFE; prior authorization is routine.

8. What if I have adenomyosis too?
UFE can improve adenomyosis-related bleeding, but outcomes are less predictable than for pure fibroids.

9. Is radial (wrist) access safer?
Radial access lowers bleeding risk and allows immediate walking; many centers now offer it.

Future Directions in UFE Research

  • Biodegradable particles that maintain occlusion then dissolve, potentially reducing ovarian impact.
  • Combined UFE + MR-guided focused ultrasound for very large or pedunculated fibroids.
  • Artificial-intelligence flow-mapping to shorten procedure times and cut radiation by up to 40 %.
  • Ongoing NIH-funded trials are exploring relugolix (GnRH-antagonist) pre-treatment to debulk fibroids before embolization for even faster symptom relief.

Key Takeaways

  1. UFE delivers 85 %-90 % long-term symptom relief with a < 3 % major-complication rate—matching surgical efficacy without removing the uterus.
  2. Recovery averages 7-11 days, saving thousands in indirect costs and minimizing workplace downtime.
  3. Level-1 fertility data now support pregnancy after UFE, with outcomes comparable to myomectomy.
  4. For the millions seeking an alternative to hysterectomy, UFE stands as the most thoroughly studied, uterus-preserving option in 2025.
Stay In Touch Contact Us